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Objectives: It has been postulated that ischaemia-reperfusion occurs in intermittent claudication resulting in neutrophil 
activation and release of soluble mediators, increasing systemic vascular permeability and enhancing atherogenesis. 
Methods: We measured neutrophil deformability, plasma thromboxane levels, and urinary microalbumin excretion i 30 
male claudicants, and i0 age- and sex-matched controls, before and after exercise to maximum walking distance. Blood was 
taken from an antecubital vein. 
Results There was an increase in urinary microalbumin excretion after exercise in claudicants. Statistically significant 
increases inthe median and 90th percentile transit imes (markers of neutrophil deformability)for isolated neutrophils from 
blood drawn 5 min after exercise in the claudicants were observed with no change in control subjects. Plasma thromboxane 
concentrations i  claudicants increased within 10 min post-exercise. Plasma concentrations i  controls were significantly 
lower throughout the study period. In the claudicant group, a positive correlation between the percentage change in the 
median transit time for neutrophils, and the percentage change in plasma thromboxane at 60 rain post-exercise was 
found. 
Conclusions" The results lend further support to the concept of ischaemia-reperfusion events in patients with intermittent 
claudication, leading to a systemic increase in vascular permeability asa result of endothelial injury or dysfunction (a 
crucial step in atherogenesis), associated with thromboxane production and neutrophil activation. We suggest that the 
above changes may contribute to the increased mortality seen in such patients. 
Key Words: Neutrophils; Thromboxane; Intermittent claudication. 
Introduction 
It is accepted that severe tissue ischaemia followed by 
reperfusion has major adverse systemic effects, 1 espe- 
cially on the lungs. 2'3 Evidence suggests a central role 
for neutrophils 2'4-7 and thromboxane A28-1° in a 
sequence of events leading to vascular endothelial cell 
damage and resulting in a generalised increase in 
vascular permeability (quantified by small increases in 
renal permeability reflected by changes in urinary 
11 13 protein excretion - microalbuminuria - ). A causal 
relationship between eutrophil activation and throm- 
boxane A 2 has been demonstrated ~17 and activated 
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neutrophils may cause damage by release of oxygen- 
derived free radicals and proteolytic enzymes, and 
blockage of microvessels, i  
Intermittent claudication, a common manifesta- 
tion of peripheral occlusive arterial disease, affects at 
least 5% of men over 50 years 19'2° and is associated 
with a high cardiovascular mortality rate. 2°-23 It has 
been postulated that patients with intermittent claudi- 
cation undergo a series of ischaemia-reperfusion 
injuries and that the above neutrophil-related mecha- 
nisms may contribute to the increased mortality 
experienced by such patients. 18'24~2s Activated neu- 
trophils undergo structural changes that result in 
decreased eformability. 29 Previous studies have used 
filtration rates of neutrophil suspensions to assess 
activation and changes in flow properties after inter- 
mittent claudication. 25"27 We used a cell transit ana- 
lyser (CTA), 29'3° a sensitive indicator of white cell 
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activation, to measure transit times through a micro- 
pore filter for a large number of individual neu- 
trophils. Thromboxane A2 has been stated to rise in 
patients with peripheral occlusive arterial disease 
following exercise, 32 but no supporting data were 
presented in this paper, or correlated with other 
markers of endothelial or neutrophil response. Throm- 
boxane is released uring ischaemia in animal mod- 
els, 1° and has a number of adverse actions including 
increasing vascular permeability by directly altering 
endothelial cell architecture, or indirectly through 
interaction with neutrophils. 8'1° Here, we have carried 
out measurements of thromboxane l vels in parallel 
with studies on neutrophil rheology using systemic 
blood, and a marker of generalised endothelial perme- 
ability (microalbuminuria) before and after exercise in 
patients with intermittent claudication. 
Materials and Methods 
Ethical committee approval and informed consent 
were obtained for this study. Thirty male patients with 
intermittent~ claudication (median age 63 years, range 
43-73) were recruited from vascular outpatient clinics. 
Ten control subjects were selected from a local male 
choir (median age 64 years, range 49-71). Those with 
uncontrolled hypertension, diabetes mellitus, inflam- 
matory rheumatological conditions, or on drugs likely 
to interfere with neutrophil function (e.g. calcium 
antagonists uch as nifedipine) were excluded. The 
patients had a mean resting ankle brachial pressure 
index (ABPI) of 0.58 (range 0.42--0.78), compared to 
1.18 (range 1.04--1.39) for controls. 
Having emptied their bladders, patients rested 
for 1.5 h then emptied their bladders again, producing 
a mid-stream urine specimen (MSU). Fifteen millilitres 
of blood was taken from an antecubital vein, via an 
indwelling cannula, for neutrophil testing and 5ml for 
thromboxane B 2 (TXB2). Blood was collected in sterile 
tubes containing EDTA 3~ as anticoagulant. The 
patients were then exercised to their maximum walk- 
ing distance on a treadmill at 3.2km/h and an incline 
of 12.5%. Controls exercised for a total of 4 min (200m) 
at the same settings. The mean maximum walking 
distance was 165m (range 83-310m) and all patients 
had a decrease in their ankle systolic pressures (mean 
of 61mmHg, range 28-114mmHg) after exercise rela- 
tive to pre-exercise values. All the controls howed an 
increase in ankle systolic pressure after exercise. Blood 
was taken via the cannula at 5 rain post-exercise for 
neutrophil testing and at 10, 20, and 60min post- 
exercise for TXB 2 levels. Another MSU was taken lh 
post-exercise. Blood for TXB 2 was immediately centri- 
fuged at 2000g for 10 min; the plasma was aspirated 
and snap-frozen in liquid nitrogen. The urine speci- 
mens were also snap-frozen. Microalbuminuria was 
determined using a double-antibody 125I-radioimmu- 
noassay (Diagnostic Products Corporation, Walling- 
ford, U.K.). The result was expressed as an albumin/ 
creatinine ratio (ACR) in rag/mmol to compensate for 
changes in urinary flow during the investigation. 
TXB2 levels were determined using a ELISA 
technique (Biotrack, Amersham Life Science, Amer- 
sham, U.K.). 
Neutrophils were prepared within 30min of 
sampling. Preparation followed standard procedures 
previously described 31'33 using a double density gra- 
dient of histopaque-1077 over histopaque-1119 (Sigma 
Diagnostics, Dorset, U.K.). This method yields > 97% 
viable neutrophils (trypan blue exclusion). The neu- 
trophils were suspended in 20% autologous plasma 
(in phosphate-buffered saline, Sigma Diagnostics, 
Dorset, U.K.) at a concentration of 2 × 105 cells/ml 
and allowed to equilibrate at 37°C for 20 min before 
analysis with the CTA. The CTA provides transit imes 
in ms for a large number of individual neutrophils 
passing through a filter with thirty 8/~m diameter 
pores. 29'3° A pressure of 400Pa was used to drive the 
flow of neutrophils through the pores, and each transit 
was electronically sensed and registered as a voltage 
pulse. The width of these pulses was analysed by 
computer and taken as a measure of transit time. 
Approximately 1000 cells were analysed in each 
sample and transit time percentiles calculated. 
All results were expressed as mean _+ S.E.M. (stan- 
dard error of the mean) unless otherwise stated. Pre- 
and post-exercise values were compared using Stu- 
dent's paired t-test with p<0.05 being taken as 
statistically significant. Thromboxane l vels in claudi- 
cants and controls were compared using the Student's 
unpaired t-test. Spearman's rank correlation test was 
used to determine the correlation between percentage 
change in neutrophil transit times and percentage 
changes in thromboxane. 
Results 
The CTA data for patients and controls is summarised 
in Table 1. The data showed statistically significant 
increases in the transit ime for neutrophils in systemic 
blood taken from patients after exercise. There was a 
relatively small change in the median transit times 
representing the whole population of neutrophils, but 
there was a much greater shift within the sub- 
Eur J Vasc Endovasc Surg Vol 10, July 1995 
Thromboxane and neutrophil changes in claudicants 33 
Table 1. Pore transit imes (milliseconds) for neutrophils pre- and post-exercise forclaudicants and controls 
Transit imepre-exercise(ms) Transit timepost-exercise(ms) Percentage change pStudent's pairedt-test 
Patients (n = 30) 
Median 4.6 + 0.2 
90th percentile 12.3 ± 0.9 
Controls (n = 10) 
Median 3.2 + 0.2 
90th percentile 9.0 + 1.1 
5.0±0.2 9.0±4.2 0.040 
14.6±1.3 20.2±8.0 0.018 
3.4±0.2 7.6±4.2 0.11 
9.1±1.0 4.2±6.1 0.50 
population of slower flowing cells (90th percentile). 
There was no statistically significant percentage 
change in transit imes for controls after exercise. The 
data shows a difference between controls and patients 
for the median and 90th percentile transit times pre- 
and post-exercise. However, valid comparison is not 
possible because a filter malfunction meant that the 
filter used for the patients could not be used for the 
whole of the control group. Comparing post-exercise 
to pre-exercise transit imes is valid. 
The percentage change in ACR (microalbumi- 
nuria) showed a statistically significant increase I h 
after exercise of 32.0 + 14.4% (p = 0.034, Student's 
paired t-test). Controls showed no change in ACR 
post-exercise. The data showing median ACR values 
are summarised in Table 2. 
Table 2. Microalbuminuria (ACR) fo r  c laud icants  and  cont ro l s  
Patients (n = 30) Controls (n= 10) 
ACR pre-exercise* 0.57 (0.36-1.41) 0.50 (0.4~0.72) 
ACR post-exercise* 0.68 (0.33-2.49) 0.52 (0.32M}.79) 
*data is not normally distributed and therefore median and 
Data for thromboxane B2 levels are shown graph- 
ically in Figure 1. Plasma thromboxane concentrations 
in claudicants rose for all time points after exercise 
(p < 0.001 compared to pre-exercise; Student's paired 
800 - 
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Timing of sample (rain) 
interquartile range given.Fig. 1. Systemic plasma thromboxane 
levels (mean _+ S.E.M.) at pre-exercise (time point O) and at 10, 20, and 
60min post-exercise in patients with intermittent claudication 
[(ll)n = 30] and controls[(©)n = 101. 
t-test). Plasma concentrations in controls were lower 
than those in claudicants (p<0.0005; Student's 
unpaired t-test) throughout he study period but 
showed a rise at 10, 20, and 60min post-exercise 
(p < 0.05 compared to pre-exercise; Student's paired 
t-test). There was a statistically significant positive 
correlation between the percentage change in the 
median transit time for the whole population of 
neutrophils, and the percentage change in peak 
plasma thromboxane at 60 min post-exercise (Spear- 
man's rank correlation coefficient = 0.423; 
0.05 > p > 0.02). 
Discussion 
Intermittent claudication is a common presentation of
peripheral vascular disease and although the disease 
in the lower extremities eems to follow a benign 
course, 2°'23 it is associated with a cardiovascular 
mortality 2-3 times that of the general population 2°-23 
reflecting the systemic nature of atherosclerosis. The 
calf muscles of patients with intermittent claudication 
have been shown to become ischaemic on exercise as 
gauged by changes in transcutaneous oxygen pres- 
sure 34 and blood pH 35 measurements. It has been 
postulated therefore that these patients undergo a 
series of ischaemia-reperfusion events that activate 
neutrophils 25'27 and release soluble mediators (such as 
thromboxanel°), both causing systemic increases in 
vascular permeability 24"2s and enhanced atherogene- 
sis.  36 A link between neutrophils and thromboxane 
has been shown in animal models of severe 
ischaemiaJ 4-~7 
Microalbuminuria has been used as a measure of 
increased vascular permeability 11"12 and therefore an 
indirect measure of the systemic effects of ischaemia- 
reperfusion injury. 13 Our results confirm the previous 
findings of increased microalbuminuria n ~atients 
26.28 with intermittent claudication after exercise. • 
Neutrophil activation in intermittent claudication 
has previously been examined using filtration meth- 
25 27 28 ods ' and intravital microscopy. Filtration meth- 
ods rely on structural changes in the neutrophils, 
reducing their deformability after activation. 32 We 
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have used a CTA because it combines the advantages 
of filtration methods and single pore or pipette 
methods by providing data on individual cells at a 
reasonable rate of acquisition. 3° Our results have 
confirmed previous findings of decreased eform- 
ability of neutrophils, manifest as increased transit 
times, after exercise. They show, moreover, that a sub- 
population of cells are more responsive than the whole 
population (i.e. the 90th percentile transit time 
increases more than the median), suggesting that not 
all neutrophils react equally to claudication. 
Thromboxane has been shown to be associated 
with ischaemia in animal models. 1° Our results show 
a rise in thromboxane after exercise. Moreover, a 
positive correlation between eutrophil activation and 
thromboxane changes following claudication has been 
shown, analogous to that seen in animal models of 
more severe ischaemia. Whether the elevation of 
thromboxane directly induces the change in neu- 
trophil transit imes is uncertain because in the present 
study thromboxane l vels continue to rise for 60 min, 
whereas neutrophil changes have been shown to 
reverse over this time. 27 However, we 25 have pre- 
viously found that neutrophil filterability is still 
significantly decreased at 60 rain post-exercise. Inhibi- 
tion of cyclooxygenase and thromboxane synthetase 
have been shown, however, to reduce neutrophil 
accumulation in skin abrasion preparations in rab- 
bits, 15 and thromboxane receptor antagonists inhibit 
the ischaemia-induced oxidative burst of neutro- 
phils. 14 The rise in thromboxane in controls may be 
due to an element of small vessel atherosclerosis in
these patients, some of whom have been smokers and 
as a process of ageing, or may indicate that a degree of 
muscle ischaemia during exercise is normal. The site 
of production of thromboxane in ischaemia-reperfu- 
sion is not clean Ketoconazole, a specific inhibitor of 
platelet hromboxane synthesis, does not affect hrom- 
boxane levels in plasma after ischaemia-reperfusion. 9 
Other potential sources include white blood cells, 
endothelial cells, and fibroblasts. 
What is the significance of the above findings? 
Microalbuminuria s an indicator of systemic vascular 
permeability and has been noted to be proportional to 
the severity of injury in burns and traumaY -is It is a 
marker of morbidity and death from cardiovascular 
disease. 37'38 Epidemiological studies have shown a 
correlation between the white cell count (especially 
neutrophils) and the risk of myocardial infarction and 
39 - • stroke. Activation of neutrophils magnifies the 
effects of limb ischaemia by microvascular obstruction 
and endothelial damage by the release of oxygen- 
derived free radicals and proteases. 7'1s This effect is 
not limited to the local microcirculation, and the 
neutrophil plays a central role in the pathogenesis of
ischaemia-reperfusion injury and adult respiratory 
distress yndrome. 1s'4°'41 Thromboxane has a number 
of adverse actions including vasoconstriction, 
enhanced capillary permeability, platelet aggregation, 
membrane destabilisation, and cytolysis of endothelial 
cells. 42 It may modulate permeability directly by 
altering endothelial cell architecture and cytoskeleton 
or indirectly through interaction with neutrophils. 8'~° 
Thromboxane is believed to be an "aggressive" media- 
tor of lethality in sepsis and septic shock. 43 
This study, therefore, adds further support o the 
suggestion that patients with intermittent claudication 
undergo repeated bouts of ischaemia nd reperfusion 
which may cause systemic injury on a small scale, and 
may lead to enhanced atherogenesis and increased 
mortality. It has been previously proposed that inter- 
mittent claudication can be treated with five words: 
"stop smoking and keep walking". 44 There would 
seem, therefore, to be a conflict between the methods 
to improve the local circulatory compromise and the 
possible adverse systemic effects resulting from such 
treatment. Thus, we would suggest that in addition to 
optimising local treatment, either in the form of a 
structured exercise programme or a procedure to re- 
open the occluded artery (e.g. angioplasty), some form 
of systemic protective drug is also required. 
In this study we have looked only at systemic 
changes following intermittent claudication, but the 
pulmonary microcirculation may modify the systemic 
neutrophil response by trapping less deformable cells 
coming from the ischaemic limb. If such an effect does 
exist one might expect neutrophils isolated from 
femoral vein blood to have longer transit times than 
those from systemic blood, at least immediately after 
exercise. 27 If a soluble mediator is responsible for 
systemic activation of neutrophils one would not 
expect to find such a difference. Further studies to 
answer these questions are currently underway. 
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